المؤلفون: Datta Gupta SS; Department of Nuclear Medicine., Shamim SA; Department of Nuclear Medicine.; Department of Gastroenterology., Gamanagatti S; Department of Radiodiagnosis., Gupta P; Department of Nuclear Medicine., Khan MA; Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India., Mallia MB; Radiopharmaceuticals Division, Bhabha Atomic Research Center, Mumbai, India., Chirayil V; Radiopharmaceuticals Division, Bhabha Atomic Research Center, Mumbai, India., Dash A; Radiopharmaceuticals Division, Bhabha Atomic Research Center, Mumbai, India., Bal C; Department of Nuclear Medicine.

المصدر: Nuclear medicine communications [Nucl Med Commun] 2024 Jun 01; Vol. 45 (6), pp. 510-518. Date of Electronic Publication: 2024 Apr 05.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8201017 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5628 (Electronic) Linking ISSN: 01433636 NLM ISO Abbreviation: Nucl Med Commun Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular*/complications , Carcinoma, Hepatocellular*/diagnostic imaging , Liver Neoplasms*/complications , Liver Neoplasms*/diagnostic imaging , Portal Vein*/diagnostic imaging , Ethiodized Oil*/therapeutic use , Venous Thrombosis*/diagnostic imaging , Venous Thrombosis*/drug therapy , Chelating Agents*/therapeutic use , Chelating Agents*/chemistry, Humans ; Pilot Projects ; Male ; Female ; Middle Aged ; Aged ; Radioisotopes/therapeutic use ; Adult ; Treatment Outcome